Regeneron Pharmaceuticals, Inc.
IT ˙ ETLX ˙ US75886F1075
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT
SecurityIT:4REGN / Regeneron Pharmaceuticals, Inc.
InstitutionKestra Advisory Services, LLC
Latest Disclosed Ownership4,470 shares
Latest Disclosed Value $ 3,453,811
Kestra Advisory Services, LLC reports 1.48% increase in ownership of 4REGN / Regeneron Pharmaceuticals, Inc.

On April 30, 2026 - Kestra Advisory Services, LLC filed a 13F-HR form disclosing ownership of 4,470 shares of Regeneron Pharmaceuticals, Inc. (IT:4REGN) valued at $3,453,811 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,405 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 1.48% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,470 65 1.48 3,454 1.59 0.0131
2026-02-13 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,405 571 14.89 3,400 57.73 0.0140
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,834 151 4.10 2,156 11.48 0.0099
2025-08-15 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,683 -1,222 -24.91 1,933 -37.85 0.0094
2025-05-14 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,905 -1,835 -27.23 3,111 -35.22 0.0151
2025-02-10 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,740 52 0.78 4,801 -31.71 0.0262
2024-11-13 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,688 533 8.66 7,031 8.67 0.0387
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,155 50 0.82 6,469 10.09 0.0362
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,105 1,167 23.63 5,876 35.52 0.0394
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,938 664 15.54 4,337 23.29 0.0351
2023-11-13 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,274 -17 -0.40 3,517 14.08 0.0346
2023-08-11 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,291 -264 -5.80 3,083 -17.61 0.0309
2023-05-12 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,555 -1,777 -28.06 3,743 -18.08 0.0406
2023-01-31 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,332 725 12.93 4,568 152,166.67 0.0406
2022-11-01 2022-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 5,607 -383 -6.39 4 0.00 0.0413
2022-11-01 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,607 -383 3,862 0.0413
2022-08-12 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,990 -1,431 -19.28 4 -40.00 0.0364
2022-07-20 2022-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 7,421 943 14.56 5 25.00 0.0540
2022-04-26 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 7,421 943 5,183 0.0540
2022-07-25 2021-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 6,478 -770 -10.62 4 0.00 0.0414
2022-01-20 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,478 -770 4,091 0.0414
2022-07-25 2021-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 7,248 452 6.65 4 33.33 0.0439
2021-10-19 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,248 452 4,386 0.0439
2022-07-26 2021-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 6,796 1,850 37.40 4 50.00 0.0431
2021-07-28 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,796 1,850 3,796 0.0431
2022-07-27 2021-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 4,946 1,855 60.01 2 100.00 0.0297
2021-05-10 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,946 1,855 2,340 0.0297
2022-07-28 2020-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 3,091 3,058 9,266.67 1 -100.00 0.0171
2021-01-20 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,091 3,058 1,478 0.0171
2022-07-29 2020-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 33 33 1,447,000 0.0270
2020-11-12 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 33 33 1,447 0.0270
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.